CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Incyte Corp. Company Snapshot
Incyte Corp. operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Incyte Corp. with three other companies in this sector in the United States: Albany Molecular Research Incorporated (2015 sales of $402.36 million of which 54% was API), Five Prime Therapeutics Inc ($379.80 million ), and Insys Therapeutics Incorporated ($330.80 million of which 100% was Non-Drug Products).

Sales Analysis. During the year ended December of 2015, sales at Incyte Corp. were $753.75 million. This is an increase of 47.4% versus 2014, when the company's sales were $511.50 million. This was the fourth straight year of sales growth at Incyte Corp..
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Incyte Corp.
  Stock Performance Chart for Incyte Corp.
 
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 102.02
(Figures in U.S. Dollars)
1 Week -5.3%   13 Weeks 16.5%  
4 Weeks 24.4%   52 Weeks -6.5%  
 
Incyte Corp. Key Data:
  Ticker: INCY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Commercial Physical Research
  2015 Sales 753,751,000
(Year Ending Jan 2016).
Employees: 692
  Currency: U.S. Dollars Market Cap: 19,206,180,425
  Fiscal Yr Ends: December Shares Outstanding: 188,258,973
  Share Type: Common Closely Held Shares: 1,331,899
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.